Merus NV
NASDAQ:MRUS

Watchlist Manager
Merus NV Logo
Merus NV
NASDAQ:MRUS
Watchlist
Price: 45.49 USD 2.56% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
Merus NV?
Write Note

Merus NV
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Merus NV
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Merus NV
NASDAQ:MRUS
Cash from Financing Activities
$487.4m
CAGR 3-Years
36%
CAGR 5-Years
123%
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Cash from Financing Activities
-$33.2m
CAGR 3-Years
-19%
CAGR 5-Years
9%
CAGR 10-Years
N/A
ProQR Therapeutics NV
NASDAQ:PRQR
Cash from Financing Activities
-€2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Cash from Financing Activities
-$52.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
argenx SE
XBRU:ARGX
Cash from Financing Activities
$1.3B
CAGR 3-Years
5%
CAGR 5-Years
25%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Cash from Financing Activities
-$571k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Merus NV
Glance View

Market Cap
3.1B USD
Industry
Biotechnology

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. The company is headquartered in Utrecht, Utrecht and currently employs 121 full-time employees. The company went IPO on 2016-05-19. The firm develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as well as MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.

MRUS Intrinsic Value
25.57 USD
Overvaluation 44%
Intrinsic Value
Price

See Also

What is Merus NV's Cash from Financing Activities?
Cash from Financing Activities
487.4m USD

Based on the financial report for Sep 30, 2024, Merus NV's Cash from Financing Activities amounts to 487.4m USD.

What is Merus NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
123%

Over the last year, the Cash from Financing Activities growth was 113%. The average annual Cash from Financing Activities growth rates for Merus NV have been 36% over the past three years , 123% over the past five years .

Back to Top